These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20877276)

  • 1. Endocannabinoids rein in pain outside the brain.
    Lovinger DM
    Nat Neurosci; 2010 Oct; 13(10):1155-6. PubMed ID: 20877276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid mechanisms of pain modulation.
    Hohmann AG; Suplita RL
    AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system and pain.
    Guindon J; Hohmann AG
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.
    Alvarez-Jaimes LJ; Palmer JA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1644-59. PubMed ID: 21466449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endogenous cannabinoid system and its role in nociceptive behavior.
    Cravatt BF; Lichtman AH
    J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of cannabinoids in multiple sclerosis.
    Teare L; Zajicek J
    Expert Opin Investig Drugs; 2005 Jul; 14(7):859-69. PubMed ID: 16022575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty pain cures.
    Imming P
    Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endocannabinoids and psychiatric disorders: the road ahead].
    Mechoulam R
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S5-6. PubMed ID: 20512265
    [No Abstract]   [Full Text] [Related]  

  • 9. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
    Clapper JR; Moreno-Sanz G; Russo R; Guijarro A; Vacondio F; Duranti A; Tontini A; Sanchini S; Sciolino NR; Spradley JM; Hohmann AG; Calignano A; Mor M; Tarzia G; Piomelli D
    Nat Neurosci; 2010 Oct; 13(10):1265-70. PubMed ID: 20852626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid analgesia.
    Walker JM; Huang SM
    Pharmacol Ther; 2002 Aug; 95(2):127-35. PubMed ID: 12182960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reader's response to "Endocannabinoids--the brain's own marijuana--may be linked to the metabolic syndrome".
    Armentano P
    MedGenMed; 2006; 8(4):57. PubMed ID: 17427301
    [No Abstract]   [Full Text] [Related]  

  • 12. Endocannabinoids and the control of energy homeostasis.
    Kunos G; Osei-Hyiaman D; Liu J; Godlewski G; Bátkai S
    J Biol Chem; 2008 Nov; 283(48):33021-5. PubMed ID: 18694938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addiction and pain: cannabinoid and opioid interactions.
    Tucci S
    Curr Drug Targets; 2010 Apr; 11(4):392. PubMed ID: 20196743
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic potential of the endocannabinoid system in the brain.
    Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
    Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.
    Schlosburg JE; Blankman JL; Long JZ; Nomura DK; Pan B; Kinsey SG; Nguyen PT; Ramesh D; Booker L; Burston JJ; Thomas EA; Selley DE; Sim-Selley LJ; Liu QS; Lichtman AH; Cravatt BF
    Nat Neurosci; 2010 Sep; 13(9):1113-9. PubMed ID: 20729846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular mechanisms underlying the interaction between cannabinoid and opioid system.
    Parolaro D; Rubino T; Viganò D; Massi P; Guidali C; Realini N
    Curr Drug Targets; 2010 Apr; 11(4):393-405. PubMed ID: 20017730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid system involvement in brain reward processes related to drug abuse.
    Solinas M; Yasar S; Goldberg SR
    Pharmacol Res; 2007 Nov; 56(5):393-405. PubMed ID: 17936009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain.
    Sagar DR; Staniaszek LE; Okine BN; Woodhams S; Norris LM; Pearson RG; Garle MJ; Alexander SP; Bennett AJ; Barrett DA; Kendall DA; Scammell BE; Chapman V
    Arthritis Rheum; 2010 Dec; 62(12):3666-76. PubMed ID: 20722027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids and related fatty acid derivatives in pain modulation.
    Walker JM; Krey JF; Chu CJ; Huang SM
    Chem Phys Lipids; 2002 Dec; 121(1-2):159-72. PubMed ID: 12505698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin.
    Kurrikoff K; Inno J; Matsui T; Vasar E
    Eur J Neurosci; 2008 Apr; 27(8):2147-55. PubMed ID: 18412633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.